DRUGS MADE IN AMERICA ACQUISITION CORP. (DMAAR) Free cash flow
DRUGS MADE IN AMERICA ACQUISITION CORP. (DMAAR) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to DMAARSource: SEC XBRL filings · For reference only · Not investment advice
More DMAAR financial trends
DMAAR RevenueDMAAR Net incomeDMAAR Net marginDMAAR Gross profitDMAAR Gross marginDMAAR Operating incomeDMAAR Operating marginDMAAR Operating cash flowDMAAR Capital expendituresDMAAR Return on equityDMAAR Stock buybacksDMAAR Dividends paidDMAAR Total assetsDMAAR Total liabilitiesDMAAR Shareholders’ equityDMAAR overview →